Key Developments
- CMS corrected FY 2027 Medicare payment figures for inpatient psychiatric facilities, effective October 1.
- HRSA awarded $89.3 million to expand rural substance use treatment, recovery, overdose response, and workforce capacity.
- FDA is seeking input on safeguards for early-phase ibogaine trials through November 20.
- Nebraska reported new rural crisis-support and mental-health telehealth activity, and North Carolina directed more than $17 million to rural PMH and substance use services.
Federal Policy Update
CMS Corrects FY 2027 Inpatient Psychiatric Facility Payment Rates
- Final correction, issued and effective October 1: CMS recalculated the wage-index budget-neutrality factor and reduced the federal per-diem base rate for facilities meeting quality-reporting requirements from $912.40 to $912.13. The electroconvulsive therapy payment per treatment changed from $688.59 to $688.38. The Federal Register correction and CMS implementation instructions contain the revised figures.
HRSA Awards $89.3 Million for Rural Substance Use Services
- Awards announced September 25: HRSA awarded $62.7 million for integrated treatment and recovery services, $12.6 million for overdose response, $10 million for technical assistance, and $4 million for planning through the Rural Communities Opioid Response Program. The awards reach organizations in 45 states and one territory. View the HRSA announcement and FY 2026 RCORP-Impact award list.
FDA Seeks Input on Investigational Ibogaine Trials through November 20
- Informational request for information, issued October 5: FDA is seeking input on dose escalation, eligibility, care setting, cardiac and neurologic monitoring, stopping rules, informed consent, and independent safety oversight for early-phase ibogaine, a plant-based psychoactive compound, trials. Adults with opioid use disorder and adults with post-traumatic stress disorder are initial priority populations for federally supported research. Review the FDA announcement and Federal Register notice.
CMS Creates an Optional Medicaid CCBHC State-Plan Benefit
- CMS State Medicaid Director Letter 26-004 establishes an optional Medicaid state-plan benefit for Certified Community Behavioral Health Clinic services. The benefit includes nine required service categories, including crisis services, outpatient treatment, peer and family support, psychiatric rehabilitation and care coordination.
SAMHSA Awards $96 Million Through the STREETS Program
- SAMHSA awarded eight communities $96 million over four years through Safety Through Recovery, Engagement, and Evidence-based Treatment and Support. The awards fund treatment, recovery services, and related supports for people experiencing homelessness and substance use or mental-health conditions.
CMS Revises Medicaid Reentry Demonstration Policy
- Under revised CMS policy, future adult reentry demonstrations may generally provide Medicaid services for up to 60 days before release. The required minimum service package includes case management, medications for substance use disorders when clinically appropriate, and a 30-day supply of prescription medications at release.
State Policy Update
North Carolina Funds Rural Crisis, Psychosis, Addiction, and Maternal Mental Health Services
- Funding announced October 7: North Carolina allocated $4 million to Certified Community Behavioral Health Clinics, $4 million to mobile crisis teams, $3 million to medications for opioid use disorder, $3 million to coordinated specialty care for first-episode psychosis, $2.9 million to rural crisis partnerships, and $800,000 to expand NC MATTERS. See the state announcement and CMS confirmation.
Nebraska Reports Rural Crisis-Support and Mental-Health Telehealth Activity
- Funded implementation announced October 13: Within Nebraska’s broader Rural Health Transformation Program, 19 community mental-health crisis-debriefing sessions supported communities during the state’s 2026 wildfires, and app-based telehealth tools are connecting rural law enforcement and first responders with trained mental-health professionals during crises. CMS also identified planned expansion of mobile and behavioral-health services in its October 13 announcement.
Maryland’s Companion-Chatbot Law Takes Effect
- Maryland’s HB 952, effective October 1, establishes requirements for operators of companion chatbots. The law addresses disclosures, protocols for indications of self-harm, and protections applying to minor users.
California Requires Protection of Clinical Judgment in AI-Informed Care
- California’s AB 1979 requires healthcare entities using clinical decision-support tools to take reasonable steps to ensure those tools do not replace a licensed professional’s independent clinical judgment. The law also requires reasonable steps to ensure that the tools do not discriminate on the basis of protected characteristics.
International Policy Update
UK Review Calls for Earlier Support and Stronger Specialist Mental Health Care
- A UK government-commissioned review into mental health conditions, ADHD, and autism recommends providing support according to need before, during, and after assessment, while retaining timely diagnosis and specialist care for people who need them. Its recommendations include that diagnosis should remain available when clinically needed, but it should no longer be the main gateway to support.
Published October 2026.
This summary was informed by human-guided AI tools. Readers are encouraged to review the supporting links for full information.
